{
"NDC": {
"NDCCode": "84381-110-01",
"PackageDescription": "1 VIAL, SINGLE-DOSE in 1 CARTON (84381-110-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE",
"NDC11Code": "84381-0110-01",
"ProductNDC": "84381-110",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Rapiblyk",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Landiolol",
"DosageFormName": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
"RouteName": "INTRAVENOUS",
"StartMarketingDate": "20250519",
"EndMarketingDate": null,
"MarketingCategoryName": "NDA",
"ApplicationNumber": "NDA217202",
"LabelerName": "AOP Orphan Pharmaceuticals GmbH",
"SubstanceName": "LANDIOLOL HYDROCHLORIDE",
"StrengthNumber": "280",
"StrengthUnit": "mg/1",
"Pharm_Classes": "Adrenergic beta1-Antagonists [MoA], beta-Adrenergic Blocker [EPC]",
"DEASchedule": null,
"Status": "Active",
"LastUpdate": "2025-05-20",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20261231",
"StartMarketingDatePackage": "20250519",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}